Bruno Nervi

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100

Bruno Nervi, Pablo Ramírez, Michael P. Rettig et al. · Blood · 2008 · 481 citations · Full text

Medicine, Oncology, Pharmacology +13

Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial

María Elvira Balcells, Luis Rojas, Nicole Le Corre et al. · PLoS Medicine · 2021 · 94 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

AMD3100: CXCR4 Antagonist and Rapid Stem Cell-Mobilizing Agent

Amanda F. Cashen, Bruno Nervi, John F. DiPersio · Future Oncology · 2007 · 91 citations

Medicine, Hematology, Immunology +17

Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis

Zachary J. Ward, Magdalena Walbaum, Benjamín Walbaum et al. · The Lancet Oncology · 2021 · 91 citations · Full text

Medicine, Health Care Management, Health Policy +17

Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID β2mnull mice

Bruno Nervi, Michael P. Rettig, Julie Ritchey et al. · Experimental Hematology · 2007 · 74 citations · Full text

Life Sciences, Cell Biology, Immunology +16